Skip to main content
OpenTrials
Completed

NCT Number: NCT07723508

BeauSaki Bird's Nest Peptide Efficacy

The goal of this clinical trial is to learn whether BeauSaki Edible Bird's Nest Peptide Product can improve facial skin conditions in healthy adult participants. The main questions it aims to answer are:

Can daily intake of the edible bird's nest peptide product improve facial skin hydration, elasticity, brightness, wrinkles, pores, spots, redness, and skin texture after 8 weeks?

Is the edible bird's nest peptide product well tolerated by participants during the study period?

Researchers will compare participants who take the edible bird's nest peptide capsule with participants who take a placebo capsule without edible bird's nest to see if the product improves facial skin conditions.

Participants will:

* Take one capsule daily for 8 weeks. * Visit the study site at baseline, week 4, and week 8 for non-invasive facial skin assessments. * Cleanse their face with water and rest under room temperature conditions for 30 minutes before each skin assessment. * Complete a brief questionnaire about perceived skin condition and product satisfaction at baseline, week 4, and week 8. * Have facial photographs taken for skin condition evaluation, with identifiable areas masked before disclosure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Facial Skin Condition

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chia Nan University of Pharmacy ＆ Science

Tainan, Taiwan, 71710

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants aged over 18 years.

Exclusion criteria

  • Individuals who are unwilling to participate voluntarily.
  • Individuals diagnosed by a physician with skin disease, liver cirrhosis, or chronic renal failure.
  • Individuals with known allergies to cosmetics, drugs, or foods.
  • Pregnant or breastfeeding individuals.
  • Individuals taking medications for chronic diseases.
  • Students taught by the principal investigator.
  • Individuals unwilling to allow their study-related photographs to be disclosed. Vegetarians.

Treatment and study plan

BeauSaki Edible Bird's Nest Peptide Product

Dietary Supplement

Participants will take one capsule daily for 8 weeks.

Placebo Capsule (matched dosing schedule)

Dietary Supplement

Participants will take one placebo capsule without edible bird's nest daily for 8 weeks.

Primary outcomes

  1. Facial Skin Analysis Parameters

    Time frame: Baseline, week 4, and week 8

    VISIA Micro-Analysis Skin Image Analyzer was utilized to measure skin spots, wrinkles, texture, pores, UV spots, brown Spots, red areas, porphyrins.

    Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.

  2. Skin Moisture

    Time frame: Baseline, week 4, and week 8

    Skin moisture meter (VapoMeter) was utilized to measure skin moisture. Units: g/m²h Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.

  3. Skin elasticity

    Time frame: Baseline, week 4, and week 8

    Skin elastometer (Soft Plus) was utilized to measure skin elasticity. Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.

Sponsors and collaborators

Lead sponsor

Chia Nan University of Pharmacy ＆ Science

Other

Registry information

Official study title

Efficacy Evaluation of BeauSaki Edible Bird's Best Peptide Product

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 23, 2026
Registry last updated
Jul 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.